Monogenic Diabetes Misdiagnosed as Type 1

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age1-25
SponsorMcGill University Health Centre/Research Institute of the McGill University Health Centre

About this trial

The study has two aims:

1. To (1a) determine the frequency of monogenic diabetes misdiagnosed as type 1 diabetes (T1D) and (2) to define an algorithm for case selection. 2. To discover novel genes whose mutations cause monogenic diabetes misdiagnosed as T1D.

Eligibility criteria

Qualifiers

Diagnosis of diabetes under the age of 25 as either type 1 or undetermined type.

Disqualifiers

Existing T1D autoantibody testing with a positive result

Trial design

Treatments tested in this trial

  • None AHT

Treatment groups

5,000 Participants
are divided into 2 treatment groups